Clinomics Europe at the 6th ACTC: „Liquid Biopsy and Precision Oncology: Where do we stand now?” meeting
We are thrilled to announce that our Senior Researcher, Dávid Kis, PhD, will present a poster at the 6th Advances in Circulating Tumor Cells: „Liquid Biopsy and Precision Oncology: Where do we stand now?” meeting on the beautiful Greek island of Skiathos between 20 – 23 of September.
Join us at the conference, where Dr. Kis will share insights on cutting-edge CTC research. Stay at the forefront of liquid biopsy and precision oncology, and don’t miss out on this hot topic!
Poster Title: CTC Quantification and Molecular Characterization by Digital PCR: Advancing Liquid Biopsy
Conference Details: https://www.erasmus.gr/microsites/1261
Recent blogs
New developments in the field of circulating tumor cells (2024)
The blog post focuses on how researchers can produce more meaningful, applicable results that directly benefit human health.
Singlera technologies 5: Panseer – detecting pan-cancer signatures years before conventional diagnosis
In the last blog of the year and the concluding chapter of the Singlera series, we are going to explore PanSeer, a blood-based screening test utilizing unique methylation signatures.
Singlera Technologies 4: Catching Pancreatic Cancer early with intricate methylation markers
Enter PDACatch, a novel assay developed to detect circulating tumor DNA methylation signatures with greater sensitivity and accuracy.